Skip to content

Our story.

Our story started in 2008 when Prof. Jouko Yliruusi and Prof. Edward Hæggström first combined their respective expertise in pharmaceutical technology and physics. This extraordinary collaboration produced a novel particle engineering technology with the ability to transform the pharmaceutical industry.

Our passion for innovation enables your drugs to reach their full potential.
Edward Hæggström

They discovered the Controlled Expansion of Supercritical Solutions (CESS®) process in 2012 at the University of Helsinki and Nanoform was founded in 2015. Since then, Nanoform has expanded rapidly, transforming into a company with global ambition. Our cutting edge nanoforming services is intended to help the global pharmaceutical industry to double its annual new medicines output. We are proud to be a Finnish success story with an international outlook.

Our nanoforming technologies, formulation and analytical services span the full range of drug development from small-molecule to large-molecule therapeutics